Ataxia telangiectasia mutated pathway disruption affects hepatic DNA and tissue damage in nonalcoholic fatty liver disease
Authors:
- 1 April 2020
- journal article
- research article
- Published by Elsevier in Experimental and Molecular Pathology
- Vol. 113, 104369
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK020541, P30 DK41296, R01 DK071111)
- National Cancer Institute (P30 CA13330)
This publication has 55 references indexed in Scilit:
- miR-26b Promotes Granulosa Cell Apoptosis by Targeting ATM during Follicular Atresia in Porcine OvaryPLOS ONE, 2012
- The DNA damage checkpoint protein ATM promotes hepatocellular apoptosis and fibrosis in a mouse model of non-alcoholic fatty liver diseaseCell Cycle, 2012
- A new role for ATMAutophagy, 2012
- NEMO and RIP1 Control Cell Fate in Response to Extensive DNA Damage via TNF-α Feedforward SignalingCell, 2011
- Nonalcoholic Fatty Liver Disease (NAFLD) Activity Score and the Histopathologic Diagnosis in NAFLD: Distinct Clinicopathologic Meanings §ΔHepatology, 2010
- Requirement of the ATM/p53 Tumor Suppressor Pathway for Glucose HomeostasisMolecular and Cellular Biology, 2010
- ATM Activation by Oxidative StressScience, 2010
- Liver Cancer Stem CellsJournal of Clinical Oncology, 2008
- IGF-1 phosphorylates AMPK-α subunit in ATM-dependent and LKB1-independent mannerBiochemical and Biophysical Research Communications, 2004
- Defect in Multiple Cell Cycle Checkpoints in Ataxia-Telangiectasia PostirradiationJournal of Biological Chemistry, 1996